PFE vs MRK: Pfizer vs Merck
Both PFE (Pfizer) and MRK (Merck) operate in the Pharma sector. They are often compared as direct peers.
$PFE · Pfizer
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Pfizer Inks Up to $10.5 Billion Deal With China’s Innovent - Bloomberg.com
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom - Reuters
Insiders Aren’t Buying Pfizer Stock at $26 and That’s Actually a Good Thing
UBS maintains Pfizer stock rating ahead of cancer drug trial results
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
$MRK · Merck
Merck & Co., Inc. (MRK) Shareholder/Analyst Call - Slideshow
Merck KGaA selects Veeva Vault CRM for global deployment
Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide – Company Announcement - Financial
Frequently Asked Questions
What is the main difference between PFE and MRK?
PFE is Pfizer (sector: Pharma). MRK is Merck (sector: Pharma). They differ in business model, geography, and product mix — catalysts that move one may not move the other.
Are PFE and MRK direct competitors?
They are in the same sector and often direct competitors. Check the latest news feed on both tickers for current competitive dynamics.
How do I track PFE and MRK news in real time?
Catalayer aggregates news from 30+ sources in real time for both PFE and MRK. Follow /stocks/PFE and /stocks/MRK for live feeds, or create a custom monitor for either.
Which stock performs better historically?
Past performance varies by timeframe and regime. Catalayer provides real-time news and AI analysis but does not provide investment advice or performance-ranked recommendations.